These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15725701)

  • 41. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver X receptor in cholesterol metabolism.
    Zhao C; Dahlman-Wright K
    J Endocrinol; 2010 Mar; 204(3):233-40. PubMed ID: 19837721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.
    Li T; Chiang JY
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G74-84. PubMed ID: 15331348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
    Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
    Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functions of Cholesterol Metabolites.
    Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S151-3. PubMed ID: 26598835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: insights from evidence on hepatic cholesterol degradation and gallstone disease in humans.
    Bertolotti M; Gabbi C; Anzivino C; Carulli L; Loria P; Carulli N
    Curr Med Chem; 2008; 15(22):2271-84. PubMed ID: 18781949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear receptors in bile acid metabolism.
    Li T; Chiang JY
    Drug Metab Rev; 2013 Feb; 45(1):145-55. PubMed ID: 23330546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis.
    Goodwin B; Kliewer SA
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G926-31. PubMed ID: 12016116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR.
    Krasowski MD; Ni A; Hagey LR; Ekins S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):39-48. PubMed ID: 20615451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice.
    Sberna AL; Assem M; Gautier T; Grober J; Guiu B; Jeannin A; Pais de Barros JP; Athias A; Lagrost L; Masson D
    J Hepatol; 2011 Jul; 55(1):154-61. PubMed ID: 21145854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism.
    Ding L; Chang M; Guo Y; Zhang L; Xue C; Yanagita T; Zhang T; Wang Y
    Lipids Health Dis; 2018 Dec; 17(1):286. PubMed ID: 30567573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear receptor regulation of cholesterol and bile acid metabolism.
    Repa JJ; Mangelsdorf DJ
    Curr Opin Biotechnol; 1999 Dec; 10(6):557-63. PubMed ID: 10600692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bile Acids Activated Receptors Regulate Innate Immunity.
    Fiorucci S; Biagioli M; Zampella A; Distrutti E
    Front Immunol; 2018; 9():1853. PubMed ID: 30150987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
    Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
    Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.
    Fiorucci S; Cipriani S; Baldelli F; Mencarelli A
    Prog Lipid Res; 2010 Apr; 49(2):171-85. PubMed ID: 19932133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
    Repa JJ; Turley SD; Lobaccaro JA; Medina J; Li L; Lustig K; Shan B; Heyman RA; Dietschy JM; Mangelsdorf DJ
    Science; 2000 Sep; 289(5484):1524-9. PubMed ID: 10968783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interplay between cholesterol and drug metabolism.
    Rezen T; Rozman D; Pascussi JM; Monostory K
    Biochim Biophys Acta; 2011 Jan; 1814(1):146-60. PubMed ID: 20570756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
    Kalaany NY; Mangelsdorf DJ
    Annu Rev Physiol; 2006; 68():159-91. PubMed ID: 16460270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.